newsfilter
← Latest News
GlobeNewswire·

Akouos to Participate in Upcoming February Virtual Investor Conferences

BOSTON, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Akouos, Inc. ("Akouos") (NASDAQ:AKUS), a precision genetic medicine company dedicated to developing potential gene therapies for individuals living with disabling hearing loss worldwide, today announced that me